Strong Revenue Growth:
Disclosed 2025 results indicate meaningful top-line expansion and double-digit recurring-revenue growth. Acquirer communications point to continued high-teens growth expectations, reinforcing momentum.
Profitability:
Acquisition materials cite robust EBITDA margins, signaling healthy, profitable operations that can fund continued scaling. This margin profile alongside a recurring-revenue mix supports resilience.
Investor Backing & Capital Strength:
Nemetschek’s definitive agreement to acquire HCSS—following prior backing by Thoma Bravo—demonstrates strong external validation and capital support. Planned alignment with established AEC/O brands suggests access to broader distribution and investment capacity.
